Sujal Shah is Chief Executive Officer of CymaBay Therapeutics, Inc.. Currently has a direct ownership of 0 shares of CBAY, which is worth approximately $0. The most recent transaction as insider was on Mar 22, 2024, when has been sold 406,670 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Sujal Shah Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 22 2024
SELL
Sale (or disposition) back to the issuer
-
406,670 Reduced 100.0%
0 Common Stock
Mar 13 2024
BUY
Exercise of conversion of derivative security
$848,625 $6.1 p/Share
139,119 Added 25.49%
406,670 Common Stock
Jan 24 2024
BUY
Grant, award, or other acquisition
-
96,250 Added 26.46%
267,551 Common Stock
Dec 11 2023
SELL
Open market or private sale
$1,323,246 $20.4 p/Share
64,865 Reduced 27.47%
171,301 Common Stock
Dec 11 2023
BUY
Exercise of conversion of derivative security
$324,325 $5.0 p/Share
64,865 Added 27.36%
172,191 Common Stock
Nov 13 2023
SELL
Open market or private sale
$1,030,673 $15.89 p/Share
64,863 Reduced 27.47%
171,301 Common Stock
Nov 13 2023
BUY
Exercise of conversion of derivative security
$324,315 $5.0 p/Share
64,863 Added 25.24%
192,156 Common Stock
Oct 09 2023
SELL
Open market or private sale
$921,026 $14.2 p/Share
64,861 Reduced 27.46%
171,301 Common Stock
Oct 09 2023
BUY
Exercise of conversion of derivative security
$324,305 $5.0 p/Share
64,861 Added 21.55%
236,162 Common Stock
Jun 06 2022
BUY
Open market or private purchase
$100,037 $1.95 p/Share
51,301 Added 23.05%
171,301 Common Stock
SS

Sujal Shah

Chief Executive Officer
Newark, CA

Track Institutional and Insider Activities on CBAY

Follow CymaBay Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CBAY shares.

Notify only if

Insider Trading

Get notified when an Cyma Bay Therapeutics, Inc. insider buys or sells CBAY shares.

Notify only if

News

Receive news related to CymaBay Therapeutics, Inc.

Track Activities on CBAY